In this early‑Alzheimer’s therapeutic space, Sedulo deployed a targeted intelligence initiative combining secondary research and trial data with primary interviews. The result was proactive flagging of competitor R&D moves and potential partnerships, informing strategic planning in a rapidly evolving market.
